The Tribunal found that the rider committed an Anti-Doping Rule Violation (ADRV) for the use of a prohibited substance or method, following an unexplained abnormality detected in his Athlete Biological Passport (ABP) in 2022.
As a consequence, the Tribunal has imposed a four-year period of ineligibility, starting on 5 February 2024 and running until 4 February 2028, in accordance with the World Anti-Doping Code and the UCI Anti-Doping Rules.
In line with the Procedural Rules of the UCI Anti-Doping Tribunal, the full decision will be published on the UCI website. The decision may be appealed before the Court of Arbitration for Sport (CAS) within one month.
The ITA manages the Athlete Biological Passport programme on behalf of the UCI, in collaboration with the Athlete Passport Management Unit (APMU) of Lausanne, which is associated with the World Anti-Doping Agency (WADA) accredited Laboratory of Lausanne. While the UCI has delegated its anti-doping programme to the ITA, it retains responsibility for results management and the prosecution of anti-doping rule violations.
The ITA will not further comment on the matter.